SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-19-000056
Filing Date
2019-11-14
Accepted
2019-11-14 16:16:27
Documents
62
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sls-20190930x10q.htm 10-Q 1072939
2 EXHIBIT 10.3 sls20190930ex103.htm EX-10.3 131409
3 EXHIBIT 31.1 sls20190930ex311.htm EX-31.1 11681
4 EXHIBIT 31.2 sls20190930ex312.htm EX-31.2 11635
5 EXHIBIT 32.1 sls20190930ex321.htm EX-32.1 10928
12 sellas-logoa10.jpg GRAPHIC 30719
  Complete submission text file 0001390478-19-000056.txt   5441744

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gale-20190930.xml EX-101.INS 1005663
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20190930.xsd EX-101.SCH 48467
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20190930_cal.xml EX-101.CAL 68364
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20190930_def.xml EX-101.DEF 185747
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20190930_lab.xml EX-101.LAB 553783
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20190930_pre.xml EX-101.PRE 330951
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 191220407
SIC: 2834 Pharmaceutical Preparations